Senicapoc

TargetMol
Product Code: TAR-T3528
Supplier: TargetMol
CodeSizePrice
TAR-T3528-5mg5mg£114.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3528-1mL1 mL * 10 mM (in DMSO)£123.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3528-10mg10mg£140.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3528-25mg25mg£179.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3528-50mg50mg£213.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3528-100mg100mg£261.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3528-200mg200mg£354.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Senicapoc is a potent inhibitor of the Gardos channel and ameliorates RBC dehydration in the SAD mouse. Senicapoc blocked Ca2+-induced rubidium flux from human RBCs with an IC50 value of 11 ? 2 nM (CLT IC50 = 100 ? 12 nM) and inhibited RBC dehydration with an IC50 of 30 ? 20 nM. Senicapoc is in treatment of Sickle Cell Disease and Sickle Cell Anemia
CAS:
289656-45-7
Formula:
C20H15F2NO
Molecular Weight:
323.343
Pathway:
Membrane transporter/Ion channel
Purity:
0.995
SMILES:
NC(=O)C(c1ccccc1)(c1ccc(F)cc1)c1ccc(F)cc1
Target:
Potassium Channel

References

Gong X, Zou L, Wang M, et al. Gramicidin inhibits cholangiocarcinoma cell growth by suppressing EGR4[J]. Artificial Cells, Nanomedicine, and Biotechnology. 48(1): 53-59. Wei T, Wang Y, Xu W, et al. KCa3.1 deficiency attenuates neuroinflammation by regulating an astrocyte phenotype switch involving the PI3K/AKT/GSK3? pathway. Neurobiology of Disease. 2019, 132: 104588 Stocker JW, et al. ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice. Blood. 2003 Mar 15;101(6):2412-8. Van Der Velden J, et al. K(Ca)3.1 channel-blockade attenuates airway pathophysiology in a sheep model of chronic asthma. PLoS One. 2013 Jun 24;8(6):e66886. Gong X, Zou L, Wang M, et al. Gramicidin inhibits cholangiocarcinoma cell growth by suppressing EGR4. Artificial Cells, Nanomedicine, and Biotechnology. 48(1): 53-59. Lu J, Dou F, Yu Z. The potassium channel KCa3.1 represents a valid pharmacological target for microgliosis-induced neuronal impairment in a mouse model of Parkinson?s disease. Journal of Neuroinflammation. 2019, 16(1): 1-14 Wei T, Wang Y, Xu W, et al. KCa3. 1 deficiency attenuates neuroinflammation by regulating an astrocyte phenotype switch involving the PI3K/AKT/GSK3? pathway[J]. Neurobiology of Disease. 2019: 104588.